Allows the administration of intercellular communication molecules as interleukins, hormones, neuropeptides and growth factors, needed for the cell differentiation, regeneration, growth and regulation. In this way, a benefit is generated increasing the availability of the drug in the tissues and organs of the system that is being affected by the disease, supplying it in specific concentrations ideal for the communication in the organism, reducing also the toxicity and the side effects.
Is a therapy approved, developed and researched in Italy, by multiple universities in the Physiologic Regulation Medicine International Society, to which we belong and of which DR. Felipe Torres is member of the scientific committee of development and research.
